Browse Nurse.com user
Log-in to view

Your Account.

Log In user
Browse

Nurse.com

Search
shopping
  • Compare Products
Search
Menu

Goal and Learning Outcomes

The goal of this continuing education program is to familiarize healthcare providers with bioterrorism and its implications for care. Part 1 focuses on the history of bioterrorism, the healthcare provider’s role in recognizing the signs and management of anthrax and plague infection, and measures the government has instituted in preparation for possible bioterrorism attacks. Part 2 focuses on the healthcare provider’s role in emergency preparedness and response and on keys to recognizing and responding to botulism and smallpox. After studying the information presented here, you will be able to:

  • Discuss the history of bioterrorism
  • Describe the signs, symptoms, and management of anthrax and plague infection
  • Discuss measures the government has instituted in case of bioterrorism attacks

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.